\-\ Texto\\:\\ \ \(0\)\
\-\ dry\\ cough\\ during\\ exam\\ \\-\\ rhonchi\\ left\\ posterior\\ chest\\ \\-\\ afebrile\\.\ \(0\)\
\-\ no\\ elevation\\ of\\ wbc\\.\\ \\ igm\\ titer\\ positive\\ \\(1\\:32\\ dilution\\)\\.\ \(0\)\
\-\ the\\ patient\\ received\\ initial\\ doses\\ of\\ ceftriaxone\\ and\\ azithromycin\\ in\\ the\\ er\\ and\\ then\\ was\\ treated\\ with\\ oral\\ levoquin\\ for\\ 5\\ days\\ at\\ home\\.\ \(0\)\
\-\ left\\ hemithorax\\ patchy\\ airspace\\ opacity\\ which\\ localizes\\ to\\ the\\ superior\\ segment\\ of\\ the\\ left\\ lower\\ lobe\\ on\\ the\\ lateral\\ projection\\.\\ airspace\\ opacity\\ cleared\\ on\\ repeat\\ imaging\\ 4\\ weeks\\ after\\ treatment\\.\ \(0\)\
\-\ pneumonia\\ \\-\\ mycoplasma\\ pneumoniae\ \(0\)\
\-\ \\â\\€\\¢\\ cap\\ \\(community\\ acquired\\ pneumonia\\)\ \(0\)\
\-\ \\â\\€\\¢\\ mycoplasma\\ pneumonia\ \(0\)\
\-\ \\â\\€\\¢\\ other\\ atypical\\ pneumonias\ \(0\)\
\-\ 28\\ year\\-old\\ with\\ persistent\\ cough\\ and\\ fever\\.\ \(1\)\
\-\ radiologists\\ often\\ do\\ not\\ know\\ the\\ causative\\ organism\\ in\\ cases\\ of\\ community\\ acquired\\ pneumonia\\ \\(cap\\)\\.\\ \\ when\\ the\\ agent\\ is\\ known\\,\\ however\\,\\ it\\ is\\ helpful\\ to\\ review\\ the\\ images\\ to\\ assist\\ clinicians\\ with\\ future\\ cases\\.\\ \\ the\\ frequency\\ quoted\\ in\\ the\\ medical\\ literature\\ supports\\ the\\ notion\\ that\\ many\\ of\\ the\\ cap\\ cases\\ thought\\ to\\ be\\ early\\ lobar\\ pneumonia\\ may\\ actual\\ be\\ bronchopneumonia\\ limited\\ to\\ a\\ single\\ lower\\ lobe\\ from\\ mycoplasmpa\\ pneumoniae\\ infection\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pneumonia\\:\\ 0\\.09546796473590567\ \(0\)\
\-\ cap\\:\\ 0\\.08834955557805445\ \(0\)\
\-\ mycoplasma\\:\\ 0\\.06937970974235814\ \(0\)\
\-\ pneumoniae\\:\\ 0\\.06937970974235814\ \(0\)\
\-\ community\\:\\ 0\\.06757371963789148\ \(0\)\
\-\ airspace\\:\\ 0\\.05569683003066867\ \(0\)\
\-\ acquired\\:\\ 0\\.049528777506694474\ \(0\)\
\-\ 1\\:32\\:\\ 0\\.047651450940359455\ \(0\)\
\-\ quoted\\:\\ 0\\.047651450940359455\ \(0\)\
\-\ mycoplasmpa\\:\\ 0\\.047651450940359455\ \(0\)\
\-\ cases\\:\\ 0\\.04616450049699134\ \(0\)\
\-\ dilution\\:\\ 0\\.04390470942381921\ \(0\)\
\-\ notion\\:\\ 0\\.04390470942381921\ \(0\)\
\-\ opacity\\:\\ 0\\.04319174982012391\ \(0\)\
\-\ levoquin\\:\\ 0\\.04171300613674805\ \(0\)\
\-\ bronchopneumonia\\:\\ 0\\.04015796790727896\ \(0\)\
\-\ ceftriaxone\\:\\ 0\\.03895178654882377\ \(0\)\
\-\ localizes\\:\\ 0\\.03895178654882377\ \(0\)\
\-\ azithromycin\\:\\ 0\\.0379662646202078\ \(0\)\
\-\ pneumonias\\:\\ 0\\.0379662646202078\ \(0\)\
\-\ titer\\:\\ 0\\.03577456133313664\ \(0\)\
\-\ cough\\:\\ 0\\.03539735004116835\ \(0\)\
\-\ igm\\:\\ 0\\.03378685981894574\ \(0\)\
\-\ cleared\\:\\ 0\\.03378685981894574\ \(0\)\
\-\ causative\\:\\ 0\\.03378685981894574\ \(0\)\
\-\ actual\\:\\ 0\\.03338627618568238\ \(0\)\
\-\ doses\\:\\ 0\\.033013341745212366\ \(0\)\
\-\ clinicians\\:\\ 0\\.03266448487419847\ \(0\)\
\-\ supports\\:\\ 0\\.0320278198165964\ \(0\)\
\-\ radiologists\\:\\ 0\\.0317355645664868\ \(0\)\
\-\ organism\\:\\ 0\\.0317355645664868\ \(0\)\
\-\ assist\\:\\ 0\\.0317355645664868\ \(0\)\
\-\ know\\:\\ 0\\.030702833556958645\ \(0\)\
\-\ \\-\\:\\ 0\\.0297037047358113\ \(0\)\
\-\ agent\\:\\ 0\\.029639534669142133\ \(0\)\
\-\ rhonchi\\:\\ 0\\.027848415015334336\ \(0\)\
\-\ dry\\:\\ 0\\.02744783138207097\ \(0\)\
\-\ projection\\:\\ 0\\.026839842282467243\ \(0\)\
\-\ lobar\\:\\ 0\\.026614584464085794\ \(0\)\
\-\ hemithorax\\:\\ 0\\.026089375012984996\ \(0\)\
\-\ future\\:\\ 0\\.025610708000328535\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.025411043539392778\ \(0\)\
\-\ lobe\\:\\ 0\\.024857571328903073\ \(0\)\
\-\ literature\\:\\ 0\\.024843301182650764\ \(0\)\
\-\ patchy\\:\\ 0\\.024764388753347237\ \(0\)\
\-\ frequency\\:\\ 0\\.02438623422033691\ \(0\)\
\-\ helpful\\:\\ 0\\.023897671725913835\ \(0\)\
\-\ elevation\\:\\ 0\\.022812965263956264\ \(0\)\
\-\ home\\:\\ 0\\.021956368826270996\ \(0\)\
\-\ 28\\:\\ 0\\.021773117195591635\ \(0\)\
\-\ repeat\\:\\ 0\\.021728258801998687\ \(0\)\
\-\ received\\:\\ 0\\.02146665587842112\ \(0\)\
\-\ afebrile\\:\\ 0\\.021340453910869816\ \(0\)\
\-\ thought\\:\\ 0\\.021257927034487176\ \(0\)\
\-\ lower\\:\\ 0\\.020776887236366084\ \(0\)\
\-\ segment\\:\\ 0\\.020150930209373592\ \(0\)\
\-\ do\\:\\ 0\\.020051745676031987\ \(0\)\
\-\ atypical\\:\\ 0\\.02001908451681057\ \(0\)\
\-\ review\\:\\ 0\\.02001908451681057\ \(0\)\
\-\ limited\\:\\ 0\\.019492066330405827\ \(0\)\
\-\ oral\\:\\ 0\\.019462609007337907\ \(0\)\
\-\ many\\:\\ 0\\.018984937923823907\ \(0\)\
\-\ single\\:\\ 0\\.018722488056705035\ \(0\)\
\-\ persistent\\:\\ 0\\.018423495418953405\ \(0\)\
\-\ er\\:\\ 0\\.017719914361880876\ \(0\)\
\-\ year\\-old\\:\\ 0\\.016966295252422794\ \(0\)\
\-\ early\\:\\ 0\\.01689275118725642\ \(0\)\
\-\ wbc\\:\\ 0\\.01683824243554493\ \(0\)\
\-\ then\\:\\ 0\\.01643765880228157\ \(0\)\
\-\ fever\\:\\ 0\\.015628446630010628\ \(0\)\
\-\ left\\:\\ 0\\.015504409771993213\ \(0\)\
\-\ initial\\:\\ 0\\.015305849423131396\ \(0\)\
\-\ positive\\:\\ 0\\.014988570758292524\ \(0\)\
\-\ superior\\:\\ 0\\.014749965930022656\ \(0\)\
\-\ often\\:\\ 0\\.014737694856862986\ \(0\)\
\-\ known\\:\\ 0\\.01461649234845308\ \(0\)\
\-\ be\\:\\ 0\\.014246018630745181\ \(0\)\
\-\ medical\\:\\ 0\\.014212485405762186\ \(0\)\
\-\ days\\:\\ 0\\.014157158357686366\ \(0\)\
\-\ during\\:\\ 0\\.014135185134723288\ \(0\)\
\-\ treated\\:\\ 0\\.013826220735588429\ \(0\)\
\-\ 5\\:\\ 0\\.013514380661860344\ \(0\)\
\-\ infection\\:\\ 0\\.01342711661660977\ \(0\)\
\-\ when\\:\\ 0\\.01322881750062706\ \(0\)\
\-\ weeks\\:\\ 0\\.013109609496762965\ \(0\)\
\-\ 4\\:\\ 0\\.012870118406373218\ \(0\)\
\-\ however\\:\\ 0\\.012861448949173354\ \(0\)\
\-\ \\(\\:\\ 0\\.011713973939089631\ \(0\)\
\-\ \\)\\:\\ 0\\.011570881493729273\ \(0\)\
\-\ to\\:\\ 0\\.011542381309269899\ \(0\)\
\-\ chest\\:\\ 0\\.011052589189500101\ \(0\)\
\-\ imaging\\:\\ 0\\.010822020672732987\ \(0\)\
\-\ posterior\\:\\ 0\\.010646694857851075\ \(0\)\
\-\ other\\:\\ 0\\.010646694857851075\ \(0\)\
\-\ it\\:\\ 0\\.010382964240719009\ \(0\)\
\-\ exam\\:\\ 0\\.01014721048621372\ \(0\)\
\-\ may\\:\\ 0\\.010131504696746617\ \(0\)\
\-\ lateral\\:\\ 0\\.00998198943580838\ \(0\)\
\-\ after\\:\\ 0\\.00955676325734704\ \(0\)\
\-\ treatment\\:\\ 0\\.009349280862707497\ \(0\)\
\-\ the\\:\\ 0\\.008967521169964916\ \(0\)\
\-\ images\\:\\ 0\\.008860885902428941\ \(0\)\
\-\ which\\:\\ 0\\.008622403174284048\ \(0\)\
\-\ that\\:\\ 0\\.007978274208426072\ \(0\)\
\-\ on\\:\\ 0\\.007825848782328953\ \(0\)\
\-\ from\\:\\ 0\\.006845598449482229\ \(0\)\
\-\ in\\:\\ 0\\.006833468596868999\ \(0\)\
\-\ not\\:\\ 0\\.006674695522929381\ \(0\)\
\-\ at\\:\\ 0\\.006258179204495314\ \(0\)\
\-\ is\\:\\ 0\\.006078819225780818\ \(0\)\
\-\ was\\:\\ 0\\.005342040660614523\ \(0\)\
\-\ no\\:\\ 0\\.0046510494632637945\ \(0\)\
\-\ patient\\:\\ 0\\.004630226653602097\ \(0\)\
\-\ for\\:\\ 0\\.00394112512779846\ \(0\)\
\-\ of\\:\\ 0\\.0031487513729186066\ \(0\)\
\-\ \\,\\:\\ 0\\.0029265953028895933\ \(0\)\
\-\ and\\:\\ 0\\.0029190649578197587\ \(0\)\
\-\ a\\:\\ 0\\.00214378271253298\ \(0\)\
\-\ \\.\\:\\ 0\\.0019188938430997988\ \(0\)\
\-\ with\\:\\ 0\\.0018973650176738878\ \(0\)\
